These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1608896)

  • 21. Reversal of lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab fragments.
    Lechat P; Mudgett-Hunter M; Margolies MN; Haber E; Smith TW
    J Pharmacol Exp Ther; 1984 Apr; 229(1):210-3. PubMed ID: 6707937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of severe digitoxin intoxication by digoxin-specific Fab antibody fragments.
    Lignian H; Vincent JL; Hallemans R
    Acta Cardiol; 1984; 39(4):301-5. PubMed ID: 6333127
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of massive digitalis poisoning (20 mg of digitoxin) with anti-digoxin antibody fragments (Fab)].
    Aeberhard P; Butler VP; Smith TW; Haber E; Eng DT; Brau J; Chalom A; Glatt B; Thébaut JF; Delangenhagen B; Morin B
    Arch Mal Coeur Vaiss; 1980 Dec; 73(12):1471-8. PubMed ID: 6779736
    [No Abstract]   [Full Text] [Related]  

  • 24. Structural aspects of conformational changes in ligand binding by antibody fragments.
    Edmundson AB; Guddat LW; Shan L; Fan ZC; Hanson BL
    Res Immunol; 1994 Jan; 145(1):56-61. PubMed ID: 8008970
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases.
    Smith TW; Butler VP; Haber E; Fozzard H; Marcus FI; Bremner WF; Schulman IC; Phillips A
    N Engl J Med; 1982 Nov; 307(22):1357-62. PubMed ID: 6752715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of fragments of human IgG to solid-phase C3b measured by enzyme-linked immunosorbent assay (ELISA).
    Hautanen A
    Scand J Immunol; 1981; 13(3):245-54. PubMed ID: 7233094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of severe digoxin toxicity with digoxin-specific antibody fragments.
    Jones M; Hawker F; Duggin G; Falk M
    Anaesth Intensive Care; 1987 May; 15(2):234-6. PubMed ID: 3605573
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on combining sites on immunoglobulin--hapten binding activity of rabbit IgG fragments cleaved by cyanogen bromide (author's transl)].
    Nakamura H
    Nihon Ketsueki Gakkai Zasshi; 1973 Aug; 36(4):497-9. PubMed ID: 4799443
    [No Abstract]   [Full Text] [Related]  

  • 29. Application of fluorescence correlation spectroscopy to hapten-antibody binding.
    Hazlett TL; Ruan Q; Tetin SY
    Methods Mol Biol; 2005; 305():415-38. PubMed ID: 15940009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The affinity of binding of digoxin to ovine anti-digoxin Fab (DIGIBIND) preparations.
    Allen G
    Biologicals; 1996 Mar; 24(1):19-24. PubMed ID: 8733598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibody affinity].
    Torosian ATs
    Usp Sovrem Biol; 1980; 89(3):419-32. PubMed ID: 6251656
    [No Abstract]   [Full Text] [Related]  

  • 32. [Production and characterization of a high affinity monoclonal antibody with digoxin and digitoxin specificity].
    Simon HU; Hubl W; Müller WD; Wolf I; Schlenvoigt G; Jäger L
    Allerg Immunol (Leipz); 1990; 36(4):343-50. PubMed ID: 2097902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colchicine-specific Fab fragments alter colchicine disposition in rabbits.
    Sabouraud AE; Urtizberea M; Cano NJ; Grandgeorge M; Rouzioux JM; Scherrmann JM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1214-9. PubMed ID: 1545388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modifying specificity of antidigoxin antibodies using insertional mutagenesis.
    Krykbaev RA; Tsantili P; Jeffrey PD; Margolies MN
    Protein Sci; 2002 Dec; 11(12):2899-908. PubMed ID: 12441388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Digitoxin poisoning: reversing ventricular fibrillation with Fab fragments of anti-digoxin antibody].
    Domart Y; Bismuth C; Schermann JM; Abuaf N; Pontal PG; Baud F; Bolo A; Gailliot M; Fournier PE
    Nouv Presse Med; 1982 Dec; 11(52):3827-30. PubMed ID: 7162976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of murine anti-human Fab antibodies for use in an immunoassay for generic quantification of human Fab fragments in non-human serum samples including cynomolgus monkey samples.
    Stubenrauch K; Wessels U; Essig U; Kowalewsky F; Vogel R; Heinrich J
    J Pharm Biomed Anal; 2013 Jan; 72():208-15. PubMed ID: 23017233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of non-digitalis binding properties of digoxin-specific Fabs using direct binding methods.
    Pullen MA; Harpel MR; Danoff TM; Brooks DP
    J Immunol Methods; 2008 Jul; 336(2):235-41. PubMed ID: 18555269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of thyroid stimulating activity within H chain fragments of TSAb-IgG by protease digestion and reduction.
    Kouki T; Inui T; Hachiya T; Okabe H; Ochi Y; Kajita Y
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):183-8. PubMed ID: 9135700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.
    Butler VP; Schmidt DH; Smith TW; Haber E; Raynor BD; Demartini P
    J Clin Invest; 1977 Feb; 59(2):345-59. PubMed ID: 299860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Features of interaction of monoclonal antibody B2 with polycyclicaromatic hydrocarbons and peptide-mimotope of benzo[a]pyrene].
    Glushko AN; Apal'ko SV; Bakulina AIu; Matveeva VA; Khrapov EA; Kostianko MV; Sil'nikov VN; Filipenko ML
    Mol Biol (Mosk); 2010; 44(4):699-707. PubMed ID: 20873230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.